← Back to all trials
Recruiting
NCT07642076
Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill Hepatic Patients Admitted to Intensive Care Unit
Conditions: Hepatic
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: PHASE4
Enrollment: 58
Sponsor: Beni-Suef University
Location: National liver institute Shibīn al Kawm
Summary
This study aims to evaluate the possible efficacy of l-carnitine in critically ill hepatic patients admitted to intensive care unit.
Eligibility Criteria
Inclusion Criteria:
* Age more than 18 years old
* male or female with confirmed liver disease admitted to intensive care unit, including:
* Acute-on-chronic liver failure (ACLF)
* Hepatic encephalopathy
* spontaneous bacterial peritonitis (SBP)
* variceal bleeding
* fulminant hepatitis
* Hepatorenal syndrome
* Ascites
* Etc
Exclusion Criteria:
* Age of less than 18 years old
* Pregnancy or Lactation
* patients have seizure
* patient on warfarin
Source: ClinicalTrials.gov (NCT07642076). StuddyBuddy aggregates publicly available trial information.
